ICD-10-CM Casefinding List for Reportable Tumors in Oregon State (2022) | Exams Cancer Cytogenetics

Page | 1 12/17/2021

Oregon State Cancer Registry

2022 ICD-10-CM Casefinding List: Short Version (Required)

EFFECTIVE DATES: 10/1/2021-9/30/2022

2022 COMPREHENSIVE ICD-10-CM Casefinding Code List for Reportable Tumors

ICD-10 Code

Explanation of Code

C00.- - C43.-,

C4A.-,

C45.- - C48.-,

C49.-

-C96.-

Malignant neoplasms (excluding category C44 and C49.A), stated or

presumed to be primary (of specified site) and certain specified histologies

C44.00, C44.09

Unspecified/other malignant neoplasm of skin of lip

C44.10-, C44.19-

Unspecified/other malignant neoplasm of skin of eyelid

C44.13-

Sebaceous cell carcinoma of skin of eyelid, including canthus

Note: Effective 10/1/2018

C44.20-, C44.29-

Unspecified/other malignant neoplasm skin of ear and external auricular

canal

C44.30-, C44.39-

Unspecified/other malignant neoplasm of skin of other/unspecified parts of

face

C44.40, C44.49

Unspecified/other malignant neoplasm of skin of scalp & neck

C44.50-, C44.59-

Unspecified/other malignant neoplasm of skin of trunk

C44.60-, C44.69-

Unspecified/other malignant neoplasm of skin of upper limb, incl. shoulder

C44.70-, C44.79-

Unspecified/other malignant neoplasm of skin of lower limb, including hip

C44.80, C44.89

Unspecified/other malignant neoplasm of skin of overlapping sites of skin

C44.90, C44.99

Unspecified/other malignant neoplasm of skin of unspecified sites of skin

C49.A-

Gastrointestinal Stromal Tumors Note: All GIST tumors are now reportable

starting in 2021 (per ICD-O-3.2), including GIST, NOS

D00.- - D05.-,

D07.- - D09

In-situ neoplasms

Note 1: Excludes carcinoma in situ tumors of the cervix (D06._)

Note 2: Excludes prostatic intraepithelial neoplasia (PIN III)

(8148/2) of the prostate. Other prostate in situ histologies are

reportable

Note 3: For D04 (carcinoma in situ of skin), excludes basal and

squamous cell in situ lesions

D13.7

Benign neoplasm of endocrine pancreas Note: Effective 1/1/2021:

Review this code to look for the following which were previously a

benign tumor of the pancreas, but is now malignant per ICD-O-3.2

• Islet cell adenoma

• Nesidioblastoma

• Islet cell adenomatosis

• Insulinoma

• Beta cell adenoma

D18.02

Hemangioma of intracranial structures and any site

D21.4, D48.1

Benign neoplasm of connective and other soft tissue of abdomen Note:

Effective 1/1/2021: Review this code to look for the following which were

previously a benign tumor of the pancreas, but is now malignant per ICD-O-

3.2 • Gastrointestinal stromal tumor, NOS/GIST, NOS/Gastrointestinal

autonomic nerve tumor/GANT/Gastrointestinal pacemaker cell tumor

(8936/1, now 8936/3)

Partial preview of the text

Download ICD-10-CM Casefinding List for Reportable Tumors in Oregon State (2022) and more Exams Cancer Cytogenetics in PDF only on Docsity!

2022 ICD- 10 - CM Casefinding List: Short Version (Required)

EFFECTIVE DATES: 10/1/2021-9/30/

2022 COMPREHENSIVE ICD- 10 - CM Casefinding Code List for Reportable Tumors ICD-10 Code Explanation of Code C00.- - C43.-, C4A.-, C45.- - C48.-, C49.-

C96.- Malignant neoplasms (excluding category C44 and C49.A), stated or presumed to be primary (of specified site) and certain specified histologies C44.00, C44.09 Unspecified/other malignant neoplasm of skin of lip C44.10-, C44.19- Unspecified/other malignant neoplasm of skin of eyelid C44.13- Sebaceous cell carcinoma of skin of eyelid, including canthus Note: Effective 10/1/ C44.20-, C44.29- Unspecified/other malignant neoplasm skin of ear and external auricular canal C44.30-, C44.39- Unspecified/other malignant neoplasm of skin of other/unspecified parts of face C44.40, C44.49 Unspecified/other malignant neoplasm of skin of scalp & neck C44.50-, C44.59- Unspecified/other malignant neoplasm of skin of trunk C44.60-, C44.69- Unspecified/other malignant neoplasm of skin of upper limb, incl. shoulder C44.70-, C44.79- Unspecified/other malignant neoplasm of skin of lower limb, including hip C44.80, C44.89 Unspecified/other malignant neoplasm of skin of overlapping sites of skin C44.90, C44.99 Unspecified/other malignant neoplasm of skin of unspecified sites of skin C49.A- Gastrointestinal Stromal Tumors Note: All GIST tumors are now reportable starting in 2021 (per ICD-O-3.2), including GIST, NOS D00.- - D05.-, D07.- - D In-situ neoplasms Note 1: Excludes carcinoma in situ tumors of the cervix (D06._) Note 2: Excludes prostatic intraepithelial neoplasia (PIN III) (8148/2) of the prostate. Other prostate in situ histologies are reportable Note 3: For D04 (carcinoma in situ of skin), excludes basal and squamous cell in situ lesions D13.7 (^) Benign neoplasm of endocrine pancreas Note: Effective 1/1/2021: Review this code to look for the following which were previously a benign tumor of the pancreas, but is now malignant per ICD-O-3.
- Islet cell adenoma
- Nesidioblastoma
- Islet cell adenomatosis
- Insulinoma
- Beta cell adenoma D18.02 Hemangioma of intracranial structures and any site D21.4, D48.1 Benign neoplasm of connective and other soft tissue of abdomen Note: Effective 1/1/2021: Review this code to look for the following which were previously a benign tumor of the pancreas, but is now malignant per ICD-O- 3.2 • Gastrointestinal stromal tumor, NOS/GIST, NOS/Gastrointestinal autonomic nerve tumor/GANT/Gastrointestinal pacemaker cell tumor (8936/1, now 8936/3)

2022 COMPREHENSIVE ICD- 10 - CM Casefinding Code List for Reportable Tumors ICD-10 Code Explanation of Code D23.9 Other benign neoplasm of skin Benign carcinoid tumors of other sites Note: Effective 1/1/2021: Review these codes to look for the following which were previously benign and borderline tumors, but are now malignant per ICD-O- 3.2 • Aggressive digital papillary adenoma (c44_) (8408/1, but now 8408/3) D3A._ Benign carcinoid tumors of other sites Note: Effective 1/1/2021: Review these codes to look for the following which were previously benign and borderline tumors, but are now malignant per ICD-O-3.2 • Carcinoid tumor, argentaffinoma, NOS (8240/1, now 8241/3) • Enterochromaffin-like cell carcinoid, NOS (8242/1, now 8241/3) D32.- Benign neoplasm of meninges (cerebral, spinal and unspecified) D33.- Benign neoplasm of brain and other parts of central nervous system D35.00 - D35.02 Benign neoplasm of adrenal gland Note: Effective 1/1/2021: Review this code to look for the following which was previously a benign (8700/0) tumor of the adrenal gland, but is now malignant per ICD-O-3.2 (8700/3)

Pheochromocytoma
Adrenal medullary paraganglioma
Chromaffin paraganglioma
Chromaffin tumor
Chromaffinoma D35.2 - D35.4 Benign neoplasm of pituitary gland, craniopharyngeal duct and pineal gland D37.8 Neoplasm of uncertain behavior of other specified digestive organs (includes uncertain behavior of pancreas) Note: Effective 1/1/2021: Review this code to look for the following histologies which were previously borderline tumors, but are now malignant per ICD-O-3.
Pancreatic endocrine tumor, NOS (C259, 8150/1, now 8150/3)
Islet cell tumor, NOS (C259, 8150/1, now 8150/3)
Glucagonoma, NOS (C259, 8152/1, now 8152/3)
Alpha cell tumor, NOS (C259, 8152/1, now 8152/3)
Glucagon-like peptid-producing tumor (C259, 8152/1, now 8152/3)
Somastostatinoma, NOS (8156/1, now 8156/3)
Somatostatin cell tumor, NOS (8156/1, now 8156/3)
Endocrine tumor, functioning, NOS (8158/1, now 8158/3)
ACTH-producing tumor (8158/1, now 8158/3) D42.-, D43.- Neoplasm of uncertain or unknown behavior of meninges, brain, CNS D44.3 - D44.5 Neoplasm of uncertain or unknown behavior of pituitary gland, craniopharyngeal duct and pineal gland D44.6 Neoplasm of uncertain behavior of carotid body Note: Effective 1/1/2021: Review this code to look for the following histologies which were previously borderline tumors, but are now malignant per ICD-O-3.2 • Carotid body tumor/Carotid body paraganglioma (8692/1, now 8692/3) D44.7 Neoplasm of uncertain behavior of aortic body and other paraganglia Note: Effective 1/1/2021: Review this code to look for the following histologies which were previously borderline tumors, but are now malignant per ICD-O- 3.2 • Paraganglioma, NOS (8680/1, now 8680/3) • Sympathetic paraganglioma (8681/1, now 8681/3) • Parasympathetic paraganglioma (8682/1, now 8682/3) • Glomulus jugulare tumor, NOS/jugular paraganglioma/juglotympanic paraganglioma (8690/1, now 8690/3) • Aortic body tumor/aortic body paraganglioma/aorticopulmonary paraganglioma (8691/1, now 8691/3) • Extra-adrenal paraganglioma, NOS/nonchromaffin paraganglioma, NOS/chemodectoma (8693/1, now 8693/3)

2022 COMPREHENSIVE ICD- 10 - CM Casefinding Code List for Reportable Tumors ICD-10 Code Explanation of Code R87.614 (^) Cytologic evidence of malignancy on smear of cervix R87.624 (^) Cytologic evidence of malignancy on smear of vagina 1 Note: Pilocytic/juvenile astrocytoma M-9421 moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. However, SEER registries will CONTINUE to report these cases and code behavior as /3 (malignant). NOTE: Cases with the codes listed below should be screened as registry time allows. Experience in the SEER registries has shown that using the supplemental list increases casefinding for benign brain and CNS, hematopoietic neoplasms, and other reportable diseases Note: VIN 3, VAIN 3, AIN 2-3, AIN 3 (squamous intraepithelial neoplasia Grade 3) and juvenile astrocytoma, pilocytic astrocytoma, and piloid astrocytoma ARE reportable to the Oregon State Cancer Registry. Exclusions : Basal/squamous cell carcinoma of skin. However, if skin of genitalia then it is reportable to OSCaR.

in situ carcinoma of cervix uteri and PIN III are not reportable. _ Please refer to your standard setter(s) for specific reporting requirements before using the Casefinding List._** Reference: Surveillance Epidemiology and End Results (SEER) Program. Comprehensive ICD- 10 - CM Casefinding list for reportable tumor.

2022 ICD- 10 - CM Casefinding List: Supplemental

Effective for cases diagnosed 10/1/2021-9/30/ NOTE: Cases with the codes listed below should be screened as registry time allows. Experience in the SEER registries has shown that using the supplemental list increases casefinding for benign brain and CNS, hematopoietic neoplasms, and other reportable diseases NOTE: For the 2022 ICD- 10 - CM Supplemental Casefinding List please visit the SEER website: https://seer.cancer.gov/tools/casefinding/icd- 10 - cm-casefinding-list.20220105.pdf

ICD-10-CM Casefinding List for Reportable Tumors in Oregon State (2022), Exams of Cancer Cytogenetics

Related documents

Partial preview of the text

Download ICD-10-CM Casefinding List for Reportable Tumors in Oregon State (2022) and more Exams Cancer Cytogenetics in PDF only on Docsity!

2022 ICD- 10 - CM Casefinding List: Short Version (Required)

EFFECTIVE DATES: 10/1/2021-9/30/

2022 ICD- 10 - CM Casefinding List: Supplemental